A California medical technology startup plans to expand the Research Triangle Park facility it bought in 2022, adding 50 jobs and spending up to $65 million on the project. Science Corp. in Alameda, Calif., is developing brain-computer interface devices …
TruLab, a provider of technology for overseeing drug clinical trials, has relocated to new offices in Research Triangle Park (RTP) to support its rapid growth and development. The company has signed a two-year lease for 10,000 square feet of space in …
Verona Pharma announced it has received FDA approval for Ohtuvayre (Ensifentrine), a maintenance treatment for chronic obstructive pulmonary disease (COPD) in adult patients. It is the first inhaled product available for the disease and is delivered …
Millions of consumers know Bayer as the aspirin company. Some even know it’s the Alka-Seltzer company. Investors know it as the German pharmaceutical, life sciences and agricultural giant that bought Monsanto in 2018. Now Bayer is buying a bigger bite of …
As NCBiotech’s Vice President of Talent and Culture Development, I have the privilege of observing and shaping our organization’s culture. On our 40th anniversary, I’ve been reflecting on the critical role that our staff, culture and collaboration play in …
In the largest capital investment ever in North Carolina’s life sciences, Novo Nordisk plans to invest $4.1 billion to expand its fill and finish operations in Johnston County, creating 1,000 new jobs and adding 1.4 million square feet of new manufacturing …
North Carolina-based Advanced Medicine Partners has announced a new financing agreement led by Deerfield Management, with additional support from ARCH Venture Partners and other investors. Once complete, this latest funding round of $32 million will bring …
The Foundation Fighting Blindness has awarded Opus Genetics, a Research Triangle Park drug development startup focused on inherited diseases of the retina, $1.7 million in funding to help advance two preclinical therapy candidates. Opus said the new …
Durham-based restor3d this week announced it has received $70 million in financing by closing $55 million in Series A funding by private investors and securing $15 million in debt financing. The designer and manufacturer of 3D-printed orthopedic implants …
As we approach North Carolina Biotechnology Center's 40th anniversary, it’s important to consider the unique qualities that distinguish our organization and highlight the collaborative nature of our staff, who generate NCBiotech's contributions to …
Durham-based Deep Blue Medical Advances has been honored with the Angel Capital Association (ACA) 2024 Luis Villalobos Award in the life sciences category. The prestigious award signifies the most ingenious and innovative ideas recently backed by members …
Daniel R. Saban, Ph.D., founder and chief scientific officer of Duke University spinout Piximune Therapeutics was honored with the 2024 Cogan Award from the Association for Research in Vision and Ophthalmology (ARVO), the world’s largest association of eye …
The Bezos Center for Sustainable Protein has launched at North Carolina State University. The Bezos Earth Fund awarded NC State $30 million over five years to lead a center of excellence to create a biomanufacturing hub for dietary proteins that are …
CSL Seqirus, a global vaccine maker with a massive manufacturing plant in Holly Springs, has won a federal contract to produce a stockpile of vaccines in case of a pandemic of avian influenza, or bird flu. Under terms of the $22 million contract, awarded …
An industry consortium funded by a federal agency has chosen Allucent, a Cary-based clinical research organization, for its initial project award for a decentralized clinical trial involving the next generation of COVID-19 vaccines. The Rapid Response …
Five startup life sciences companies have emerged as regional winners of the North Carolina Biotechnology Center’s 2024 statewide Venture Challenge. The companies (listed below) are the top picks by panels of judges from each NCBiotech region outside the …
New research funded in part by the North Carolina Biotechnology Center shows that bioengineered platelets can be used to stop bleeding and enhance wound healing in animal models of trauma. Ultimately, the synthetic platelets may hold promise in human …
The “Accelerate NC Career Celebration” at the North Carolina Biotechnology Center on May 7, 2024, brought together key players in the complex ecosystem that makes North Carolina a global leader in life sciences manufacturing. Photo by SP Murray/NCBiotech …
The North Carolina Biotechnology Center awarded 71 grants and loans totaling $2,757,090 to universities, bioscience companies and non-profit organizations in the third quarter of its fiscal year. The awards, made in January, February and March, will …
The 5th BioAgTech World Congress, produced in partnership with the North Carolina Biotechnology Center, North Carolina Plant Sciences Initiative (NC PSI) at North Carolina State University, and the Research Triangle Regional Partnership, made its Raleigh, …
